![Gottlieb[1]](https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F557081%2Fgottlieb1.jpg&w=479&h=281&op=resize)
Illumina Adds Former FDA Commissioner Scott Gottlieb to Its Board of Directors
The move should be helpful as the DNA-sequencing specialist develops diagnostic tests that require his former agency's approval.
Illumina
ILMN
ILMN
$299.92
$1.00
0.3%
Price as of February 18, 2020, 4:30 p.m. EST
View Interactive ILMN Charts
The company develops, manufactures, and markets next-generation life-science tools and integrated systems to analyze genetic variations and biological functions.
Interactive Chart
News & Analysis: Illumina
The Fool has written over 400 articles on Illumina.
Is Illumina Stock a Buy?
Illumina’s share of the sequencing market, new collaboration agreement with Roche, and growth in the clinical oncology business position it for long-term revenue growth.
Why Illumina Stock Declined by 11% in January
A confluence of worries over genetic privacy and fear of an economic downturn have investors worried over Illumina's prospects.
The 3 Most Important Things to Know About Illumina's Q4 Results
There was one surprise with the genomic sequencing leader's latest update.
Illumina Inc (ILMN) Q4 2019 Earnings Call Transcript
ILMN earnings call for the period ending December 31, 2019.
3 Things You Can Count On With Illumina's Q4 Earnings Results
These are pretty much slam dunks for the company's upcoming quarterly update.
Illumina and Roche Combine For Genomics Oncology Deal
The two companies aim to make significant advances in cancer research and make genomics accessible to more patients.
3 Things We Might Hear From Illumina Next Week
Will the gene sequencing company announce news that boosts its shares at the J.P. Morgan Healthcare Conference?
Here’s Why Illumina Shares Barely Budged When It Gave Up On Its Takeover to The Tune Of $98 Million
DNA sequencing giant Illumina dropped a deal that would have brought it complementary technology. Going it alone might be a better bet for the company and investors.
Better Buy: Illumina vs. Thermo Fisher Scientific
Which of these two genetics stocks is more likely to continue rising in value?
